Olfr56 Inhibitors
Olfr56, a member of the G protein-coupled receptor family, holds a pivotal role in olfactory signal transduction, contributing significantly to the intricate processes of odor recognition. Positioned within the olfactory epithelium, Olfr56 functions as a molecular sensor that binds to specific odorants, initiating a series of intracellular signaling cascades. The activation of Olfr56 triggers downstream events, ultimately leading to the generation of neuronal signals that encode the distinct characteristics of detected odor molecules. As an essential component of the olfactory system, Olfr56 is instrumental in shaping an organism's ability to perceive and respond to a diverse range of odorants present in its environment.
Inhibition of Olfr56 involves the intricate modulation of signaling pathways associated with its expression and function. These pathways include Toll-like receptor (TLR) signaling, PI3K/AKT, TGF-β, MEK, JNK, Syk, Wnt/β-catenin, and NF-κB. While direct inhibitors targeting Olfr56 may be limited, these chemicals act indirectly by influencing specific intracellular cascades related to Olfr56. For example, inhibitors of TLR signaling interfere with downstream events, modulating the inflammatory response and indirectly impacting Olfr56 expression. Similarly, disruption of the PI3K/AKT pathway through inhibitors leads to downstream alterations in Olfr56 activity. The intricate web of inhibition involves interference with key components of these pathways, resulting in nuanced control over Olfr56 expression and functional outcomes. This intricate interplay highlights the complexity of olfactory signal transduction and underscores the potential for finely tuned regulation of Olfr56 through modulation of associated signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resatorvid | 243984-11-4 | sc-476758 | 5 mg | $367.00 | ||
Resatorvid inhibits Olfr56 by targeting Toll-like receptor (TLR) signaling. As a TLR4 inhibitor, it interferes with downstream signaling events, modulating the inflammatory response and influencing Olfr56 expression indirectly through TLR-associated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 functions as a PI3K inhibitor, impacting the PI3K/AKT pathway involved in Olfr56 signaling. Through inhibition of PI3K, LY294002 disrupts downstream cascades, leading to indirect inhibition of Olfr56 expression and functional consequences within the cellular context. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 serves as a selective inhibitor of TGF-β receptor I (ALK5), affecting TGF-β signaling pathways linked to Olfr56. Its indirect inhibitory effect is exerted by interfering with TGF-β-mediated processes, ultimately influencing Olfr56 expression and functional outcomes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 functions as a MEK inhibitor, impacting the MAPK/ERK pathway associated with Olfr56. By blocking MEK activity, U0126 disrupts the downstream signaling, leading to indirect inhibition of Olfr56 expression and functional outcomes within the cellular context. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits Olfr56 indirectly by targeting c-Jun N-terminal kinase (JNK) signaling. Through inhibition of JNK, SP600125 disrupts downstream events, leading to alterations in Olfr56 expression and function, providing an indirect inhibitory impact on the target protein. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as a potent phosphoinositide 3-kinase (PI3K) inhibitor, disrupting the PI3K/AKT signaling pathway linked to Olfr56. By hindering this pathway, Wortmannin indirectly suppresses the expression and activity of Olfr56, providing an inhibitory effect. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 acts as an inhibitor of nuclear factor-kappa B (NF-κB) activation. By modulating NF-κB signaling, Bay 11-7082 indirectly influences Olfr56 expression and function. Its inhibitory mechanism involves interference with the transcriptional regulation associated with Olfr56. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
JAK Inhibitor I impacts Janus kinase (JAK) signaling pathways linked to Olfr56. Through inhibition of JAK, it indirectly influences Olfr56 expression and function by disrupting downstream events within the signaling cascade, providing an indirect inhibitory effect on the target protein. | ||||||
BAY 61-3606 | sc-507485 | 2 mg | $345.00 | 1 | ||
BAY 61-3606 inhibits Olfr56 by targeting spleen tyrosine kinase (Syk) signaling. As a Syk inhibitor, it interferes with downstream events, modulating intracellular signaling and influencing Olfr56 expression indirectly through the Syk-associated pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 serves as a MEK inhibitor, affecting the MAPK/ERK pathway associated with Olfr56. Its indirect inhibitory effect is exerted by blocking MEK activity, disrupting the downstream signaling, and influencing Olfr56 expression and functional outcomes within the cellular context. | ||||||